Enzastaurin in the treatment of recurrent glioblastoma: a promise that did not materialize

J Clin Oncol. 2010 Mar 1;28(7):1097-8. doi: 10.1200/JCO.2009.26.1149. Epub 2010 Feb 1.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Neoplasms / drug therapy*
  • Clinical Trials, Phase III as Topic
  • Glioblastoma / drug therapy*
  • Humans
  • Indoles / therapeutic use*
  • Protein Kinase C / antagonists & inhibitors*
  • Protein Kinase C beta
  • Recurrence
  • Vascular Endothelial Growth Factor Receptor-2 / physiology

Substances

  • Indoles
  • Vascular Endothelial Growth Factor Receptor-2
  • Protein Kinase C
  • Protein Kinase C beta
  • enzastaurin